| mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0061 |
0.9 |
| mRNA |
Compound 23 citrate |
CTRPv2 |
pan-cancer |
AAC |
-0.0059 |
0.9 |
| mRNA |
XMD14-99 |
GDSC1000 |
pan-cancer |
AAC |
0.0058 |
0.9 |
| mRNA |
LRRK2-IN-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.0064 |
0.9 |
| mRNA |
Erlotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.0058 |
0.9 |
| mRNA |
ifosfamide |
CTRPv2 |
pan-cancer |
AAC |
-0.0088 |
0.9 |
| mRNA |
alvocidib |
CTRPv2 |
pan-cancer |
AAC |
-0.0078 |
0.9 |
| mRNA |
embelin |
GDSC1000 |
pan-cancer |
AAC |
0.0055 |
0.9 |
| mRNA |
Docetaxel |
gCSI |
pan-cancer |
AAC |
0.0084 |
0.9 |
| mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0057 |
0.9 |